254 related articles for article (PubMed ID: 30156029)
21. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: a Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995-2010).
Montinaro V; Boston SE; Buracco P; Culp WT; Romanelli G; Straw R; Ryan S
Vet Surg; 2013 Nov; 42(8):943-50. PubMed ID: 24433298
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.
Kruse MA; Holmes ES; Balko JA; Fernandez S; Brown DC; Goldschmidt MH
Vet Pathol; 2013 Jul; 50(4):704-8. PubMed ID: 23269349
[TBL] [Abstract][Full Text] [Related]
23. Retrospective Evaluation of Whole Body Computed Tomography for Tumor Staging in Dogs with Primary Appendicular Osteosarcoma.
Talbott JL; Boston SE; Milner RJ; Lejeune A; Souza CH; Kow K; Bacon NJ; Hernandez JA
Vet Surg; 2017 Jan; 46(1):75-80. PubMed ID: 27906470
[TBL] [Abstract][Full Text] [Related]
24. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
25. Canine multilobular osteosarcoma of the skull with metastasis.
Losco PE; Diters RW; Walsh KM
J Comp Pathol; 1984 Oct; 94(4):621-4. PubMed ID: 6595277
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo enhancement of canine pulmonary alveolar macrophage cytotoxic activity against canine osteosarcoma cells.
Kurzman ID; Shi F; Vail DM; MacEwen EG
Cancer Biother Radiopharm; 1999 Apr; 14(2):121-8. PubMed ID: 10850295
[TBL] [Abstract][Full Text] [Related]
27. Histologic prognosticators in feline osteosarcoma: a comparison with phenotypically similar canine osteosarcoma.
Dimopoulou M; Kirpensteijn J; Moens H; Kik M
Vet Surg; 2008 Jul; 37(5):466-71. PubMed ID: 18986314
[TBL] [Abstract][Full Text] [Related]
28. Osteosarcoma of the penile bone (os penis) in a dog.
Peppler C; Weissert D; Kappe E; Klump S; Kramer M; Reinacher M; Neiger R
Aust Vet J; 2009; 87(1):52-5. PubMed ID: 19178479
[TBL] [Abstract][Full Text] [Related]
29. The mitotic regulator polo-like kinase 1 as a potential therapeutic target for c-Myc-overexpressing canine osteosarcomas.
Gola C; Licenziato L; Accornero P; Iussich S; Morello E; Buracco P; Modesto P; Aresu L; De Maria R
Vet Comp Oncol; 2022 Dec; 20(4):890-900. PubMed ID: 36054794
[TBL] [Abstract][Full Text] [Related]
30. The immunotherapy of canine osteosarcoma: a historical and systematic review.
Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
[TBL] [Abstract][Full Text] [Related]
31. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma.
Alegre F; Ormonde AR; Godinez DR; Illendula A; Bushweller JH; Wittenburg LA
Vet Comp Oncol; 2020 Mar; 18(1):52-63. PubMed ID: 31381810
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and ultrasonographic appearance of hepatic metastasis in six cases of canine appendicular osteosarcoma (2005-2013).
Cesario L; Garrett LD; Barger AM; O'Brien RT; Fan TM
Aust Vet J; 2016 May; 94(5):160-5. PubMed ID: 27113987
[TBL] [Abstract][Full Text] [Related]
33. Cytological versus histopathological diagnosis in canine osteosarcoma.
Loukopoulos P; Rozmanec M; Sutton RH
Vet Rec; 2005 Dec; 157(24):784. PubMed ID: 16339991
[No Abstract] [Full Text] [Related]
34. Use of routine histopathology and factor VIII-related antigen/von Willebrand factor immunohistochemistry to differentiate primary hemangiosarcoma of bone from telangiectatic osteosarcoma in 54 dogs.
Giuffrida MA; Bacon NJ; Kamstock DA
Vet Comp Oncol; 2017 Dec; 15(4):1232-1239. PubMed ID: 27507032
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of complex karyotype changes in two canine bone tumours.
Mayr B; Eschborn U; Loupal G; Schleger W
Res Vet Sci; 1991 Nov; 51(3):341-3. PubMed ID: 1780594
[TBL] [Abstract][Full Text] [Related]
36. Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.
Morello E; Martano M; Buracco P
Vet J; 2011 Sep; 189(3):268-77. PubMed ID: 20889358
[TBL] [Abstract][Full Text] [Related]
37. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
38. Management of canine appendicular osteosarcoma.
Straw RC; Withrow SJ; Powers BE
Vet Clin North Am Small Anim Pract; 1990 Jul; 20(4):1141-61. PubMed ID: 2196734
[TBL] [Abstract][Full Text] [Related]
39. Tumor necrosis following radiation therapy and/or chemotherapy for canine osteosarcoma.
Withrow SJ; Powers BE; Straw RC; Thrall DE; Gillette EL; LaRue SM; Richter SL
Chir Organi Mov; 1990; 75(1 Suppl):29-31. PubMed ID: 2249550
[No Abstract] [Full Text] [Related]
40. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs.
Morello E; Buracco P; Martano M; Peirone B; Capurro C; Valazza A; Cotto D; Ferracini R; Sora M
J Small Anim Pract; 2001 Feb; 42(2):61-6. PubMed ID: 11263699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
